Menu
Not yet recruiting NCT07727109

The Effect of Sound-Based Interventions on Pain and Anxiety in Pediatric Patients

No phase Interventional Pain (Visceral, Somatic, or Neuropathic) Anxiety Acute

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: white noise, pink noise.
Who it may be relevant to
Registry conditions: Pain (Visceral, Somatic, or Neuropathic), Anxiety Acute. Basic parameters: 6 years — 12 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Turkey (Türkiye)
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Effects of Non-Pharmacological Auditory Interventions on Pain and Anxiety in Pediatric Patients: A Randomized Controlled Trial Comparing White and Pink Noise

Overview

This study is a prospective, three-arm, single-blind, randomized controlled clinical trial designed to evaluate the effectiveness of non-pharmacological sound-based interventions on pain and anxiety in pediatric patients. The study will be conducted at a university hospital with 150 children aged 6-12 years who require peripheral intravenous (IV) catheterization. Participants will be randomly assigned to three groups: a white noise group, a pink noise group, or a control group (standard care). Sound interventions (white or pink noise at 50-55 dB) will be administered via noise-canceling headphones for 5 minutes before and during the IV procedure. The primary outcomes will be pain levels assessed by the Visual Analog Scale (VAS) and the Wong-Baker FACES Pain Rating Scale, and anxiety levels assessed by the Children's Fear and Anxiety Scale (CFAS). The study aims to provide evidence-based, safe, and cost-effective alternatives to pharmacological pain management in pediatric clinical procedures.

Interventions

  • Behavioral white noise
    White noise will be administered at a constant intensity of 50-55 dB using noise-canceling headphones for 5 minutes before and during the peripheral intravenous (IV) catheterization procedure.
  • Behavioral pink noise
    Participants in this group will be exposed to pink noise at a constant intensity of 50-55 dB via noise-canceling headphones for 5 minutes before and during the peripheral intravenous (IV) catheterization procedure.

Primary outcome measures

  • pain intensity [Time frame: During the peripheral intravenous (IV) catheterization procedure.]
Secondary outcome measures (1)
  • Anxiety level [Time frame: During the peripheral intravenous (IV) catheterization procedure.]

Eligibility criteria

Inclusion criteria

  • Children between 7-12 years of age.
  • Scheduled for a peripheral intravenous (IV) catheterization procedure.
  • No know hearing impairment.
  • Parents/legal guardians willing and able to provide written informed consent.

Exclusion criteria

  • History of chronic pain or neurological disorder.
  • Use of any analgesic or sedative medication within 24 hours prior to the procedure.
  • Requiring emergency intervention (emergency catheterization).
  • inability to communicate or understand the procedure.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Supportive care

Study locations

Turkey (Türkiye) · 1 center
  • Tokat Gaziosmanpaşa University Hospital — Tokat Province

Identifiers

NCT: NCT07727109 · TOGU-PED-2026

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗